Dividends And Income

"ALLE looks like a bargain dividend grower because it sells security products with durable demand, has raised its dividend for 13 straight years, carries a market-beating ~1.5% yield with a ~30% payout ratio, and screens cheap on valuation after a ~20% pullback (P/E ~19.5 vs ~21.3 five-year average; DCF fair value ~$181.7 vs ~23% claimed undervaluation)."

"RJF looks undervalued for long-term dividend growth investors because it pairs a 1.4% starting yield with consistent low-teens/mid-teens double-digit dividend raises (14 straight years, 10-year dividend growth 15.3%), resilient AUA growth supported by net inflows ($52B domestic PCG net new assets in FY2025), strong profitability (ROE ~18%, net margin ~15.1%), and a valuation setup around 15.3x earnings with an intrinsic-value range implying roughly 16% undervaluation versus a ~$184.38 average of DDM/Morningstar/CFRA estimates."

"PNR looks like a buy for dividend growth because it’s a water-treatment “dividend king” with 50 straight years of dividend increases, a low 27.3% payout ratio (headroom), durable margins (ROE ~20.1%, net margin ~14.5%), and PFAS-driven municipal CapEx plus filtration/pool replacement demand supporting mid-to-high single digit dividend growth, with the recent ~20% pullback making valuation (P/E ~18.4) reasonable versus its growth profile."

"Ares Management (ARES) is a founder-led alternative asset manager with a 5%+ yield and ~23% five-year dividend growth that, despite a payout ratio over 100% and heightened private-credit risks, looks like a buy-for-income after a 50% crash that compressed valuation to a roughly mid-100s fair value."

"I view SNY as an attractive, buyable dividend growth stock given Dupixent's ~€15B sales and 25% y/y growth, a 5.4% starting yield with a 10-year dividend CAGR ~12%, a 64% payout ratio, and an 11.9x P/E that looks materially cheap versus peers despite the early-2030s Dupixent patent cliff."